Mizuho Securities USA’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.7M | Buy |
446,202
+102,476
| +30% | +$2.68M | 0.17% | 92 |
|
|
2026
Q1 | $9.65M | Sell |
343,726
-70,270
| -17% | -$1.87M | 0.23% | 86 |
|
|
2025
Q4 | $10.7M | Sell |
413,996
-102
| -0% | -$2.57K | 0.18% | 97 |
|
|
2025
Q3 | $10.3M | Buy |
414,098
+21,179
| +5% | +$523K | 0.21% | 88 |
|
|
2025
Q2 | $9.52M | Sell |
392,919
-60,836
| -13% | -$1.42M | 0.2% | 92 |
|
|
2025
Q1 | $11.5M | Sell |
453,755
-83,347
| -16% | -$2.18M | 0.25% | 77 |
|
|
2024
Q4 | $14.2M | Buy |
537,102
+169,647
| +46% | +$4.6M | 0.26% | 63 |
|
|
2024
Q3 | $10.6M | Sell |
367,455
-69,459
| -16% | -$2.03M | 0.23% | 70 |
|
|
2024
Q2 | $12.2M | Buy |
+436,914
| New | +$12M | 0.27% | 65 |
|
|
2020
Q3 | – | Sell |
-11,791
| Closed | -$366K | – | 185 |
|
|
2020
Q2 | $366K | Sell |
11,791
-532,073
| -98% | -$18.1M | 0.02% | 115 |
|
|
2020
Q1 | $16.8M | Buy |
543,864
+538,309
| +9,691% | +$18.3M | 2.49% | 4 |
|
|
2019
Q4 | $206K | Sell |
5,555
-23,746
| -81% | -$846K | 0.01% | 151 |
|
|
2019
Q3 | $999K | Buy |
+29,301
| New | +$1.07M | 0.06% | 96 |
|
|
2018
Q3 | – | Sell |
-259,706
| Closed | -$8.94M | – | 202 |
|
|
2018
Q2 | $8.94M | Sell |
259,706
-34,365
| -12% | -$1.17M | 0.92% | 18 |
|
|
2018
Q1 | $9.9M | Buy |
294,071
+274,566
| +1,408% | +$9.44M | 0.62% | 14 |
|
|
2017
Q4 | $670K | Buy |
19,505
+3,371
| +21% | +$115K | 0.04% | 121 |
|
|
2017
Q3 | $546K | Sell |
16,134
-355,928
| -96% | -$11.4M | 0.03% | 139 |
|
|
2017
Q2 | $11.9M | Buy |
372,062
+60,605
| +19% | +$1.91M | 0.61% | 7 |
|
|
2017
Q1 | $10.1M | Sell |
311,457
-488,676
| -61% | -$15.4M | 0.55% | 10 |
|
|
2016
Q4 | $24.7M | Buy |
800,133
+767,655
| +2,364% | +$23.4M | 1.03% | 8 |
|
|
2016
Q3 | $1.04M | Buy |
32,478
+26,170
| +415% | +$875K | 0.09% | 114 |
|
|
2016
Q2 | $211K | Buy |
+6,308
| New | +$201K | 0.03% | 155 |
|
|
2016
Q1 | – | Sell |
-84,320
| Closed | -$2.58M | – | 152 |
|
|
2015
Q4 | $2.58M | Buy |
+84,320
| New | +$2.65M | 0.32% | 40 |
|
|
2015
Q3 | – | Sell |
-567,746
| Closed | -$18.1M | – | 173 |
|
|
2015
Q2 | $18.1M | Buy |
567,746
+475,584
| +516% | +$15.5M | 2.15% | 8 |
|
|
2015
Q1 | $3.04M | Sell |
92,162
-29,016
| -24% | -$922K | 0.39% | 55 |
|
|
2014
Q4 | $3.58M | Sell |
121,178
-62,211
| -34% | -$1.78M | 0.35% | 55 |
|
|
2014
Q3 | $5.14M | Buy |
+183,389
| New | +$5.15M | 0.6% | 32 |
|
|
2014
Q1 | – | Sell |
-121,125
| Closed | -$3.52M | – | 87 |
|
|
2013
Q4 | $3.52M | Sell |
121,125
-41,309
| -25% | -$1.2M | 0.29% | 62 |
|
|
2013
Q3 | $4.42M | Buy |
162,434
+6,063
| +4% | +$165K | 0.28% | 50 |
|
|
2013
Q2 | $4.16M | Buy |
+156,371
| New | +$4.32M | 0.21% | 52 |
|
Other funds holding PFE
Mizuho Securities USA's PFE Position: Q2 2026 in Review
Mizuho Securities USA increased its Pfizer (PFE) stake by 30% in Q2 2026, buying an estimated $2.68M and bringing the position to 446,202 shares worth $10.7M. The position accounts for 0.17% of the portfolio, ranked #92.
Mizuho Securities USA first reported a position in PFE in Q2 2013 and has held it in 30 quarters since. The position peaked at $24.7M in Q4 2016. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Mizuho Securities USA held 446,202 shares of Pfizer worth $10.7M as of Q2 2026.
- Mizuho Securities USA bought 102,476 Pfizer shares in Q2 2026, an estimated $2.68M.
- Pfizer made up 0.17% of Mizuho Securities USA's portfolio in Q2 2026, its #92 holding.
- Mizuho Securities USA first reported a position in Pfizer in Q2 2013 and has held it in 30 quarters since.
- Mizuho Securities USA's Pfizer position peaked at $24.7M in Q4 2016.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Mizuho Securities USA's 13F filing for Q2 2026, filed 24 Jul 2026.